BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28870921)

  • 1. Significance of Circulating Galectin-3 in Patients with Pancreatobiliary Cancer.
    Shimura T; Shibata M; Gonda K; Kofunato Y; Okada R; Ishigame T; Kimura T; Kenjo A; Kono K; Marubashi S
    Anticancer Res; 2017 Sep; 37(9):4979-4986. PubMed ID: 28870921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum galectin-3 as a biomarker for screening, early diagnosis, prognosis and therapeutic effect evaluation of pancreatic cancer.
    Yi N; Zhao X; Ji J; Xu M; Jiao Y; Qian T; Zhu S; Jiang F; Chen J; Xiao M
    J Cell Mol Med; 2020 Oct; 24(19):11583-11591. PubMed ID: 32886424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
    Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
    Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer.
    Machida T; Tomofuji T; Maruyama T; Yoneda T; Ekuni D; Azuma T; Miyai H; Mizuno H; Kato H; Tsutsumi K; Uchida D; Takaki A; Okada H; Morita M
    Oncol Rep; 2016 Oct; 36(4):2375-81. PubMed ID: 27573701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum galectin-3 as a potential marker for gastric cancer.
    Cheng D; Liang B; Li Y
    Med Sci Monit; 2015 Mar; 21():755-60. PubMed ID: 25765552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S; Glinoer D; Chantrain G; Pattou F; Carnaille B; André S; Gabius HJ; Laurent G
    Thyroid; 2008 Jul; 18(7):705-12. PubMed ID: 18630998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people.
    Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS
    APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
    Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
    Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
    Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
    Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.
    Dispenzieri A; Gertz MA; Saenger A; Kumar SK; Lacy MQ; Buadi FK; Dingli D; Leung N; Zeldenrust S; Hayman SR; Kapoor P; Grogan M; Hwa L; Russell SJ; Go RS; Rajkumar SV; Kyle RA; Jaffe A
    Am J Hematol; 2015 Jun; 90(6):524-8. PubMed ID: 25753178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of preoperative elevated lipoprotein (a) with poor survival in patients with biliary tract cancers.
    Fan S; Mao Y; Ge Y; Liang Z
    Cancer Med; 2024 Jun; 13(11):e7331. PubMed ID: 38819582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure.
    Yu X; Sun Y; Zhao Y; Zhang W; Yang Z; Gao Y; Cai H; Li Y; Wang Q; Bian B; Nie J
    Int Heart J; 2015 May; 56(3):314-8. PubMed ID: 25902879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
    Fernández Moro C; Fernandez-Woodbridge A; Alistair D'souza M; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Björnstedt M; Löhr JM; Isaksson B; Verbeke C; Bozóky B
    PLoS One; 2016; 11(11):e0166067. PubMed ID: 27829047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
    de Lecea MV; Palomares T; Al Kassam D; Cavia M; Geh JLC; de Llano P; Muñiz P; Armesto D; Martinez-Indart L; Alonso-Varona A
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):636-642. PubMed ID: 27633490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma.
    Miyata T; Kitano M; Omoto S; Kadosaka K; Kamata K; Imai H; Sakamoto H; Nisida N; Harwani Y; Murakami T; Takeyama Y; Chiba Y; Kudo M
    World J Gastroenterol; 2016 Mar; 22(12):3381-91. PubMed ID: 27022220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of pancreatobiliary-type from intestinal-type periampullary carcinomas using 3.0T MRI.
    Bi L; Dong Y; Jing C; Wu Q; Xiu J; Cai S; Huang Z; Zhang J; Han X; Liu Q; Lv S
    J Magn Reson Imaging; 2016 Apr; 43(4):877-86. PubMed ID: 26395453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.